Rhythm Pharmaceuticals, Inc.

RYTM · Healthcare

$104.74

Markedsværdi: 7.21B USDUdbytteafkast: —
AdvancedEr det et godt tidspunkt at købe Rhythm Pharmaceuticals, Inc.? Spørg Copenvest AIFå et Advanced AI-bud på timing, risiko og hvad tracked investorer gør.Spørg Copenvest AI

Indlæser diagram…

Nyheder

Seneste overskrifter for denne aktie

BioPharma Dive3. sep. 2026, 12.20

An AI drug specialist zeroes in on rare forms of obesity

The Fly28. aug. 2026, 13.38

Moderna upgraded, Allstate downgraded: Wall Street's top analyst calls

24/7 Wall St.28. aug. 2026, 11.50

Here Are Friday’s Top Wall Street Analyst Research Calls: Baozun, Commerce Bancshares, Element Solutions, Evolution Petroleum, Petrobras, Rythm Pharmaceuticals, Terawulf, UMB Financial, Workday, and More

MT Newswires28. aug. 2026, 11.26

Deutsche Bank Initiates Rhythm Pharmaceuticals at Hold With $120 Price Target

Simply Wall St.26. aug. 2026, 10.15

Rhythm Pharmaceuticals (RYTM) Stock Looks Overvalued Despite Its 7x Five Year Run